Resumo

ENCISO, Leonardo J; SUAREZ, Martha L  e  ARANGO, Marcos. Results of mantle cell lymphoma treated with various immunochemotherapy regimens: A retrospective stud. rev.colomb.cancerol. [online]. 2015, vol.19, n.2, pp.71-80. ISSN 0123-9015.  https://doi.org/10.1016/j.rccan.2015.01.002.

Objective: To describe the clinical features and the treatment results achieved with the initial therapy among patients with mantle cell lymphoma treated at the National Cancer Institute (INC) between 2007 and 2011. Methods: Descriptive study, based on secondary institutional sources. Results: A total of 41 patients were included, with a mean age of 60.5 years (Standard deviation SD ± 10.5) and a good functional status. Most of them had advanced disease at initial presentation (85%). Bone marrow involvement and extra-nodal disease were frequent, as they were seen in 73% and 39% of the patients, respectively. Histopathological diagnosis of the malignancy was mainly made on lymph node tissue (56%). First line chemotherapy regimens used with an increased frequency were R CHOP and R- HyperCVAD, in 37% and 29% of the cases, respectively. After first line therapy, a complete response was achieved in 64% of the patients, median duration of the first remission was 9 months (Interquartile range IQR 0.9 - 15). Febrile neutropenia was a frequent complication, seen in 42% of the cases. Eighteen individuals received a second line of chemotherapy, with R DHAP and R HyperCVAD being the regimens most commonly administered. Conclusions: The clinical features of the patients are similar to those described in larger series of patients with the disease described elsewhere. The rate of complete responses, as well as the duration of the first remission after chemotherapy, is inferior when compared with the results of other groups that used similar treatment regimens.

Palavras-chave : Non-Hodgkin; Lymphoma; B-Cell.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )